Sign inJoin waitlistJoin the waitlist

Philip Bonomi

Physician · COBIUS HEALTHCARE SOLUTIONS

Credentials: · ·

History

COBIUS HEALTHCARE SOLUTIONS
Present

Rush University Medical Center
1973–1975
Internal Medicine
Geisinger Medical Center
1970–1973
University of Illinois
University of Illinois College of Medicine
1966–1970

Research

Determinants of tumor response and survival with erlotinib in patients with non--small-cell lung cancer
Journal of Clinical Oncology · 2004 · Last of 10 authors · 888 citations
Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument
Lung Cancer · 1995 · Last of 6 authors · 633 citations
Phase I study of Navitoclax (ABT-263), a novel Bcl-2 family inhibitor, in patients with small-cell lung cancer and other solid tumors
Journal of Clinical Oncology · 2011 · 507 citations

Mary Fidler
28 papers · 1 as a fellow
PF
Penfield Faber
27 papers
Marta Batus
19 papers
Michael Liptay
17 papers
MS
Mark Socinski
16 papers
David Johnson
13 papers
CO
Coleman Obasaju
10 papers
JC
John Coon
10 papers
DE
David Ettinger
9 papers
DS
David Spigel
9 papers
Ramaswamy Govindan
9 papers
Anthony Kim
8 papers · 8 as a resident

Clinical trials

Erlotinib and Celecoxib in Treating Patients With Stage IIIB or Stage IV Recurrent Non-Small Cell Lung Cancer
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)
2004
A Study of Oral Sapacitabine in Patients With Previously Treated Non-Small Cell Lung Cancer
Study chair · Terminated · Phase 2
Cyclacel Pharmaceuticals, Inc.
2008–2013
Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML
Study chair · Withdrawn · Phase 2
Rush University Medical Center
2001–2004
Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia
Study chair · Withdrawn · Phase 2
Rush University Medical Center
1998–1999